The Contribution of Procalcitonin, C-Reactive Protein and Interleukin-6 in the Diagnosis and Prognosis of Surgical Sepsis: An Observational and Statistical Study

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318(13):1241–1249. doi:10.1001/jama.2017.13836
   PubMed Web of Science ®Google Scholar
• Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi:10.1186/s13054-020-02950-2
   PubMed Web of Science ®Google Scholar
• Mirea L, Grinţescu I, Dumitrache C. The opportunity of substitutive doses of cortisone to septic patients. Practica Medicala. 2013;2:30. Romania.
   Google Scholar
• Lee E-H, Lee K-H, Song Y-G, et al. Discrepancy of C-reactive protein, procalcitonin and interleukin-6 at hospitalization: infection in patients with normal C-reactive protein, procalcitonin and high interleukin-6 values. J Clin Med. 2022;11(24):7324. doi:10.3390/jcm11247324
   PubMed Web of Science ®Google Scholar
• Jekarl DW, Lee SY, Lee J, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis. 2013;75(4):342–347. doi:10.1016/j.diagmicrobio.2012.12.011
   PubMed Web of Science ®Google Scholar
• Plesko M, Suvada J, Makohusova M, et al. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. Neoplasma. 2016;63(5):752–760. doi:10.4149/neo_2016_512
   PubMed Web of Science ®Google Scholar
• Carcò D, Castorina P, Guardo P, et al. Combination of interleukin-6, C-reactive protein and procalcitonin values as predictive index of sepsis in course of fever episode in adult haematological patients: observational and statistical study. J Clin Med. 2022;11(22):6800. doi:10.3390/jcm11226800
   PubMed Web of Science ®Google Scholar
• George AA, Thomas TP, Gaffoor A. The role of neutrophil/lymphocyte ratio in predicting the severity of sepsis in a tertiary care hospital in south India: a retrospective study. Int J Res Med Sci. 2020;8(5):1624–1628. doi:10.18203/2320-6012.ijrms20201490
   Google Scholar
• Gupta S, Jaswani P, Sharma RK, et al. Procalcitonin as a diagnostic biomarker of sepsis: a tertiary care centre experience. J Infect Public Health. 2019;12(3):323–329. doi:10.1016/j.jiph.2018.11.004
   PubMed Web of Science ®Google Scholar
• Yunus I, Fasih A, Wang Y, Lazzeri C. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11):e0206527. doi:10.1371/journal.pone.0206527
   PubMed Web of Science ®Google Scholar
• Chen W, Zhao L, Niu S, et al. 不同炎症因子对细菌性血流感染所致脓毒症患者的早期诊断价值 [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26(3):165–170. Chinese. doi:10.3760/cma.j.issn.2095-4352.2014.03.008
   PubMedGoogle Scholar
• Liu TB, Wang MQ, Guan W, et al. [Diagnostic values of procalcitonin, C-reactive protein and interleukin-6 in hematological diseases with bacterial infection]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26(5):1548–1552. Chinese. doi:10.7534/j.issn.1009-2137.2018.05.048
   PubMedGoogle Scholar
• Zhao Y, Li C. 生物标志物组合对急诊脓毒症和重度脓毒症患者的诊断价值 [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26(3):153–158. Chinese. doi:10.3760/cma.j.issn.2095-4352.2014.03.006
   PubMedGoogle Scholar
• Paudel R, Dogra P, Montgomery-Yates AA, et al. Procalcitonin: a promising tool or just another overhyped test? Int J Med Sci. 2020;17(3):332–337. doi:10.7150/ijms.39367
   PubMed Web of Science ®Google Scholar
• Suranadi IW, Sinardja CD, Suryadi IA. Role of procalcitonin in predicting mortality and organ dysfunction at intensive care admission. Int J Gen Med. 2022;15:4917–4923. doi:10.2147/IJGM.S362558
   PubMed Web of Science ®Google Scholar
• Liang P, Yu F. Value of CRP, PCT, and NLR in prediction of severity and prognosis of patients with bloodstream infections and sepsis. Front Surg. 2022;9:857218. doi:10.3389/fsurg.2022.857218
   PubMed Web of Science ®Google Scholar
• Jekarl DW, Lee S, Kim M, et al. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3. J Clin Lab Anal. 2019;33(9):e22996. doi:10.1002/jcla.22996
   PubMed Web of Science ®Google Scholar
• Yang Y, Xie J, Guo F, et al. Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients. Ann Intensive Care. 2016;6(1):51. doi:10.1186/s13613-016-0153-5
   PubMedGoogle Scholar
• Ryoo SM, Han KS, Ahn S, et al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: a multicenter prospective registry-based observational study. Sci Rep. 2019;9(1):6579. doi:10.1038/s41598-019-42972-7
   PubMedGoogle Scholar
• Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28(3):235–243. doi:10.1007/s00134-002-1209-6
   PubMed Web of Science ®Google Scholar
• Anush MM, Ashok VK, Sarma RI, et al. Role of C-reactive protein as an Indicator for determining the outcome of sepsis. Indian J Crit Care Med. 2019;23(1):11–14. doi:10.5005/jp-journals-10071-23105
   PubMed Web of Science ®Google Scholar
• Devran Ö, Karakurt Z, Adıgüzel N, et al. C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit. Multidiscip Respir Med. 2012;7(1):47. doi:10.1186/2049-6958-7-47
   PubMedGoogle Scholar
• Didion SP. Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature. Int J Mol Sci. 2017;18(12):2563. doi:10.3390/ijms18122563
   PubMed Web of Science ®Google Scholar
• Weidhase L, Wellhöfer D, Schulze G, et al. Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults. BMC Infect Dis. 2019;19(1):150. doi:10.1186/s12879-019-3800-2
   PubMedGoogle Scholar
• Stavem K, Hoel H, Skjaker SA, et al. Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients. Clin Epidemiol. 2017;9:311–320. doi:10.2147/CLEP.S133624
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al.; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X
   PubMed Web of Science ®Google Scholar
• Jekarl DW, Kim JY, Lee S, et al. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis. Clin Chem Lab Med. 2015;53(4):575–581. doi:10.1515/cclm-2014-0607
   PubMed Web of Science ®Google Scholar
• Yu B, Chen M, Zhang Y, et al. Diagnostic and prognostic value of interleukin-6 in emergency department sepsis patients. Infect Drug Resist. 2022;15:5557–5566. doi:10.2147/IDR.S384351
   PubMed Web of Science ®Google Scholar
• Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968. doi:10.1186/s12879-019-4618-7
   PubMed Web of Science ®Google Scholar
• Takahashi W, Nakada TA, Yazaki M, et al. Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock. 2016;46(3):254–260. doi:10.1515/cclm-2014-0607
   PubMed Web of Science ®Google Scholar
• Trásy D, Tánczos K, Németh M, et al. Delta procalcitonin is a better indicator of infection than absolute procalcitonin values in critically ill patients: a prospective observational study. J Immunol Res. 2016;2016:3530752. doi:10.1155/2016/3530752
   PubMed Web of Science ®Google Scholar
• Zeng G, Chen D, Zhou R, et al. Combination of C-reactive protein, procalcitonin, IL-6, IL-8, and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis. J Clin Lab Anal. 2022;36(7):e24505. doi:10.1002/jcla.24505
   PubMed Web of Science ®Google Scholar
• Silvestre J, Póvoa P, Coelho L, et al. Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med. 2009;35(5):909–913. doi:10.1007/s00134-009-1402-y
   PubMed Web of Science ®Google Scholar